NEW YORK, March 22 - Applied Biosystems’ remarks regarding an expected slowdown in their short-term revenues indicates that smaller biotech and genomics companies have decided to limit big expenditures on new equipment while they ride out the economic downturn, company executives and analysts said Thursday. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.